A dietary supplement rich in the soy isoflavone daidzein can reduce
the incidence of hot flushes by 52 per cent, suggests new research from
Harvard Medical School. Moreover, no negative side effects were reported
by the researchers, following the 12-week trial with 147
post-menopausal women and published in Menopause, the journal of the
North American Menopause Society. The new study, led by George
Blackburn, assigned the subjects to receive daily supplements of the
daidzein-rich isoflavone-aglycone (DRI) supplement at a dose of either
40 or 60 milligrams, or placebo for 12 weeks. At the end of the study,
the researchers report that the number of hot flushes in the group
receiving the lower dose was reduced by 52 per cent, while the women
receiving the higher dose experienced a 51 per cent reduction in the
number of hot flushes. The placebo group reported a 39 per cent
reduction in hot flush frequency.
Category: Productos
Source: NutraIngredients